Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Durapatite | 11 | 2015 | 27 | 2.750 |
Why?
|
| Coated Materials, Biocompatible | 5 | 2025 | 46 | 2.710 |
Why?
|
| Bone Morphogenetic Protein 2 | 8 | 2017 | 48 | 2.690 |
Why?
|
| Bone Substitutes | 9 | 2015 | 16 | 2.560 |
Why?
|
| Tissue Scaffolds | 7 | 2019 | 84 | 2.170 |
Why?
|
| Prostheses and Implants | 4 | 2025 | 71 | 1.880 |
Why?
|
| Biocompatible Materials | 8 | 2019 | 150 | 1.810 |
Why?
|
| Osteogenesis | 9 | 2019 | 143 | 1.780 |
Why?
|
| Titanium | 4 | 2025 | 60 | 1.600 |
Why?
|
| Polyethylene Glycols | 4 | 2015 | 168 | 1.530 |
Why?
|
| Hydrogels | 6 | 2014 | 115 | 1.510 |
Why?
|
| Polymers | 6 | 2014 | 323 | 1.240 |
Why?
|
| Rats | 17 | 2019 | 1977 | 1.220 |
Why?
|
| Bone Transplantation | 3 | 2014 | 30 | 1.060 |
Why?
|
| Tissue Engineering | 7 | 2015 | 140 | 1.040 |
Why?
|
| Vancomycin | 3 | 2019 | 39 | 1.000 |
Why?
|
| Biofouling | 1 | 2025 | 7 | 0.970 |
Why?
|
| Anti-Bacterial Agents | 3 | 2019 | 784 | 0.970 |
Why?
|
| Cartilage, Articular | 2 | 2017 | 78 | 0.960 |
Why?
|
| Polymethacrylic Acids | 3 | 2014 | 10 | 0.940 |
Why?
|
| Femoral Fractures | 3 | 2015 | 23 | 0.900 |
Why?
|
| Lactates | 2 | 2015 | 29 | 0.880 |
Why?
|
| Hydroxyapatites | 2 | 2014 | 8 | 0.870 |
Why?
|
| Bone Morphogenetic Protein 7 | 2 | 2017 | 16 | 0.860 |
Why?
|
| Recombinant Proteins | 7 | 2017 | 701 | 0.820 |
Why?
|
| Methacrylates | 4 | 2025 | 38 | 0.810 |
Why?
|
| Peptides | 2 | 2025 | 574 | 0.800 |
Why?
|
| Staphylococcus aureus | 2 | 2025 | 176 | 0.790 |
Why?
|
| Biofilms | 2 | 2025 | 82 | 0.790 |
Why?
|
| Bone Regeneration | 2 | 2019 | 15 | 0.750 |
Why?
|
| Drug Carriers | 2 | 2014 | 179 | 0.730 |
Why?
|
| Menisci, Tibial | 2 | 2017 | 25 | 0.650 |
Why?
|
| Animals | 24 | 2019 | 20631 | 0.650 |
Why?
|
| Femur | 3 | 2014 | 54 | 0.650 |
Why?
|
| Bone Marrow Cells | 4 | 2015 | 238 | 0.610 |
Why?
|
| Polyhydroxyethyl Methacrylate | 4 | 2015 | 6 | 0.580 |
Why?
|
| Staphylococcal Infections | 1 | 2019 | 129 | 0.570 |
Why?
|
| Cell Differentiation | 8 | 2017 | 1348 | 0.540 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2017 | 85 | 0.520 |
Why?
|
| Tibia | 1 | 2017 | 70 | 0.510 |
Why?
|
| Chondrocytes | 2 | 2016 | 42 | 0.510 |
Why?
|
| Surface Properties | 4 | 2025 | 278 | 0.510 |
Why?
|
| Materials Testing | 5 | 2015 | 85 | 0.510 |
Why?
|
| Microscopy, Electron, Scanning | 6 | 2014 | 108 | 0.500 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 3 | 2013 | 32 | 0.480 |
Why?
|
| Cell Survival | 6 | 2015 | 569 | 0.480 |
Why?
|
| Water | 2 | 2014 | 309 | 0.460 |
Why?
|
| Immobilized Proteins | 1 | 2014 | 6 | 0.450 |
Why?
|
| Fracture Healing | 1 | 2014 | 26 | 0.450 |
Why?
|
| Osteoblasts | 2 | 2013 | 198 | 0.440 |
Why?
|
| Transforming Growth Factor beta | 2 | 2015 | 172 | 0.440 |
Why?
|
| Sphingosine | 1 | 2014 | 20 | 0.440 |
Why?
|
| Polyesters | 1 | 2014 | 47 | 0.440 |
Why?
|
| Lysophospholipids | 1 | 2014 | 27 | 0.440 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 220 | 0.430 |
Why?
|
| Aging | 2 | 2017 | 746 | 0.430 |
Why?
|
| Cells, Cultured | 6 | 2016 | 2152 | 0.430 |
Why?
|
| Cross-Linking Reagents | 1 | 2014 | 116 | 0.410 |
Why?
|
| Surface-Active Agents | 1 | 2014 | 113 | 0.410 |
Why?
|
| Betaine | 1 | 2013 | 9 | 0.400 |
Why?
|
| Molecular Conformation | 3 | 2012 | 132 | 0.390 |
Why?
|
| Compressive Strength | 4 | 2014 | 18 | 0.380 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2017 | 621 | 0.370 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2011 | 6 | 0.370 |
Why?
|
| Click Chemistry | 1 | 2011 | 9 | 0.370 |
Why?
|
| Apatites | 1 | 2011 | 3 | 0.360 |
Why?
|
| Alloys | 3 | 2019 | 29 | 0.360 |
Why?
|
| Cellulose | 1 | 2011 | 43 | 0.350 |
Why?
|
| Nanoparticles | 3 | 2013 | 518 | 0.340 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 326 | 0.340 |
Why?
|
| Osteoarthritis, Knee | 1 | 2016 | 385 | 0.340 |
Why?
|
| Nanocomposites | 1 | 2010 | 28 | 0.340 |
Why?
|
| Organosilicon Compounds | 1 | 2010 | 4 | 0.330 |
Why?
|
| RANK Ligand | 1 | 2009 | 22 | 0.320 |
Why?
|
| Tetracycline | 1 | 2009 | 24 | 0.320 |
Why?
|
| Hot Temperature | 1 | 2010 | 130 | 0.320 |
Why?
|
| Elastomers | 1 | 2009 | 7 | 0.320 |
Why?
|
| Minerals | 1 | 2009 | 20 | 0.310 |
Why?
|
| Temperature | 1 | 2010 | 307 | 0.310 |
Why?
|
| Orthopedic Procedures | 1 | 2009 | 52 | 0.300 |
Why?
|
| Calcium | 1 | 2011 | 573 | 0.280 |
Why?
|
| Disease Models, Animal | 5 | 2017 | 2180 | 0.270 |
Why?
|
| Models, Molecular | 2 | 2011 | 1148 | 0.260 |
Why?
|
| Molecular Structure | 3 | 2014 | 384 | 0.260 |
Why?
|
| Mice | 7 | 2019 | 10827 | 0.260 |
Why?
|
| Cell Proliferation | 3 | 2017 | 985 | 0.260 |
Why?
|
| Dihydroxyphenylalanine | 1 | 2025 | 2 | 0.240 |
Why?
|
| Bacterial Adhesion | 1 | 2025 | 63 | 0.230 |
Why?
|
| Stromal Cells | 3 | 2011 | 67 | 0.230 |
Why?
|
| Male | 9 | 2017 | 29819 | 0.210 |
Why?
|
| Time Factors | 3 | 2014 | 3762 | 0.190 |
Why?
|
| Prosthesis Design | 2 | 2014 | 227 | 0.180 |
Why?
|
| Acetylene | 1 | 2001 | 3 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2015 | 619 | 0.180 |
Why?
|
| Membranes, Artificial | 1 | 2001 | 45 | 0.180 |
Why?
|
| Glutamic Acid | 1 | 2001 | 100 | 0.170 |
Why?
|
| Lipids | 2 | 2004 | 316 | 0.160 |
Why?
|
| Models, Chemical | 2 | 2015 | 136 | 0.160 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2019 | 62 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 3391 | 0.150 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 1617 | 0.140 |
Why?
|
| Humans | 9 | 2019 | 63298 | 0.140 |
Why?
|
| Periosteum | 1 | 2017 | 5 | 0.140 |
Why?
|
| Osteophyte | 1 | 2017 | 5 | 0.140 |
Why?
|
| Osteocalcin | 1 | 2017 | 47 | 0.130 |
Why?
|
| Cell Line | 2 | 2013 | 2037 | 0.130 |
Why?
|
| Rats, Inbred BB | 1 | 2017 | 134 | 0.130 |
Why?
|
| Collagen Type I | 1 | 2017 | 41 | 0.130 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 78 | 0.130 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2017 | 51 | 0.130 |
Why?
|
| Organ Size | 1 | 2017 | 172 | 0.130 |
Why?
|
| Rats, Wistar | 1 | 2017 | 185 | 0.130 |
Why?
|
| PPAR gamma | 1 | 2017 | 76 | 0.130 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2016 | 3 | 0.130 |
Why?
|
| Torsion, Mechanical | 1 | 2014 | 4 | 0.110 |
Why?
|
| Osseointegration | 1 | 2014 | 5 | 0.110 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2015 | 37 | 0.110 |
Why?
|
| Chemokine CXCL12 | 1 | 2014 | 18 | 0.110 |
Why?
|
| Computer-Aided Design | 1 | 2014 | 28 | 0.110 |
Why?
|
| X-Ray Microtomography | 1 | 2014 | 25 | 0.110 |
Why?
|
| Gene Deletion | 1 | 2016 | 308 | 0.110 |
Why?
|
| Calcium Phosphates | 1 | 2014 | 8 | 0.110 |
Why?
|
| Molecular Weight | 1 | 2014 | 187 | 0.110 |
Why?
|
| NIH 3T3 Cells | 1 | 2014 | 99 | 0.110 |
Why?
|
| Bone Density | 1 | 2015 | 134 | 0.110 |
Why?
|
| Interleukin-1beta | 1 | 2016 | 264 | 0.110 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2014 | 31 | 0.110 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2014 | 39 | 0.110 |
Why?
|
| Bone and Bones | 1 | 2015 | 139 | 0.110 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2013 | 47 | 0.100 |
Why?
|
| Cell Transdifferentiation | 1 | 2013 | 15 | 0.100 |
Why?
|
| Absorbable Implants | 1 | 2013 | 9 | 0.100 |
Why?
|
| Elasticity | 1 | 2013 | 43 | 0.100 |
Why?
|
| Knee Joint | 1 | 2016 | 297 | 0.100 |
Why?
|
| Polyethyleneimine | 1 | 2013 | 7 | 0.100 |
Why?
|
| Biomechanical Phenomena | 1 | 2014 | 270 | 0.100 |
Why?
|
| Equipment Failure Analysis | 1 | 2013 | 75 | 0.100 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2013 | 35 | 0.100 |
Why?
|
| Solubility | 1 | 2013 | 179 | 0.100 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2014 | 294 | 0.100 |
Why?
|
| Drug Compounding | 1 | 2013 | 76 | 0.100 |
Why?
|
| Delayed-Action Preparations | 1 | 2013 | 114 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 235 | 0.090 |
Why?
|
| Equipment Design | 1 | 2013 | 349 | 0.090 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 264 | 0.090 |
Why?
|
| Cyclization | 1 | 2011 | 3 | 0.090 |
Why?
|
| Alkynes | 1 | 2011 | 24 | 0.090 |
Why?
|
| Azides | 1 | 2011 | 20 | 0.090 |
Why?
|
| Evolution, Chemical | 1 | 2011 | 1 | 0.090 |
Why?
|
| Implants, Experimental | 1 | 2010 | 5 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 400 | 0.090 |
Why?
|
| Foreign-Body Reaction | 1 | 2010 | 16 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 135 | 0.090 |
Why?
|
| Weight-Bearing | 2 | 2007 | 35 | 0.090 |
Why?
|
| Collagen | 1 | 2011 | 123 | 0.080 |
Why?
|
| Body Temperature | 1 | 2010 | 45 | 0.080 |
Why?
|
| Contrast Media | 1 | 2012 | 424 | 0.080 |
Why?
|
| Myoblasts, Skeletal | 1 | 2009 | 12 | 0.080 |
Why?
|
| Freeze Drying | 1 | 2009 | 14 | 0.080 |
Why?
|
| Osteoclasts | 1 | 2009 | 48 | 0.080 |
Why?
|
| Powders | 1 | 2009 | 20 | 0.080 |
Why?
|
| Myopia | 1 | 2008 | 2 | 0.080 |
Why?
|
| Escherichia coli | 1 | 2013 | 700 | 0.070 |
Why?
|
| Chemical Engineering | 1 | 2007 | 9 | 0.070 |
Why?
|
| Biomedical Engineering | 1 | 2007 | 7 | 0.070 |
Why?
|
| Ethylene Glycol | 1 | 2007 | 10 | 0.070 |
Why?
|
| Bone Diseases | 1 | 2007 | 22 | 0.070 |
Why?
|
| Bone Development | 1 | 2007 | 31 | 0.070 |
Why?
|
| Polyurethanes | 1 | 2007 | 30 | 0.070 |
Why?
|
| Stress, Mechanical | 1 | 2007 | 112 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 738 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 1618 | 0.070 |
Why?
|
| Graft Survival | 1 | 2007 | 290 | 0.060 |
Why?
|
| Nanotechnology | 1 | 2007 | 135 | 0.060 |
Why?
|
| Acrylamides | 1 | 2005 | 15 | 0.060 |
Why?
|
| Female | 2 | 2017 | 32789 | 0.060 |
Why?
|
| Cholera Toxin | 1 | 2004 | 7 | 0.060 |
Why?
|
| Macrophages | 1 | 2009 | 1038 | 0.050 |
Why?
|
| Crystallization | 2 | 2015 | 99 | 0.050 |
Why?
|
| X-Ray Diffraction | 1 | 2003 | 61 | 0.050 |
Why?
|
| Biosensing Techniques | 1 | 2004 | 119 | 0.050 |
Why?
|
| Molecular Mimicry | 1 | 2001 | 31 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2010 | 5657 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2001 | 457 | 0.040 |
Why?
|
| Energy Transfer | 1 | 2015 | 10 | 0.030 |
Why?
|
| Adhesiveness | 1 | 2015 | 13 | 0.030 |
Why?
|
| Exocytosis | 1 | 2013 | 60 | 0.030 |
Why?
|
| Calcium Fluoride | 1 | 2012 | 2 | 0.020 |
Why?
|
| Yttrium | 1 | 2012 | 6 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2015 | 477 | 0.020 |
Why?
|
| Porosity | 1 | 2012 | 38 | 0.020 |
Why?
|
| Infrared Rays | 1 | 2012 | 19 | 0.020 |
Why?
|
| Fluorides | 1 | 2012 | 29 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2013 | 125 | 0.020 |
Why?
|
| Swine | 1 | 2012 | 374 | 0.020 |
Why?
|
| Particle Size | 1 | 2012 | 407 | 0.020 |
Why?
|
| Povidone | 1 | 2008 | 8 | 0.020 |
Why?
|
| Sclera | 1 | 2008 | 10 | 0.020 |
Why?
|
| Chickens | 1 | 2008 | 94 | 0.020 |
Why?
|
| Eye | 1 | 2008 | 54 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2007 | 31 | 0.020 |
Why?
|
| Calcification, Physiologic | 1 | 2007 | 20 | 0.020 |
Why?
|
| Urea | 1 | 2007 | 37 | 0.020 |
Why?
|
| Electrochemistry | 1 | 2004 | 27 | 0.010 |
Why?
|
| Electrodes | 1 | 2004 | 36 | 0.010 |
Why?
|
| Gold | 1 | 2004 | 226 | 0.010 |
Why?
|